Dr Capucine Baldini, Medical Oncologist, Drug Development (DITEP), Institut de Cancérologie Gustave Roussy, will be joining us for our next Virtual
Panel Series discussion on December 3rd at 11am CET.
During this interview, Dr. Baldini speaks about the work she has been doing at Gustave Roussy, how the pandemic has impacted the elderly population, and how Gustave Roussy has dealt with it.
“We didn’t have any patients that were hospitalised in the intensive care unit [with Covid-19] amongst our elderly population last month, so it’s going better than the first wave.”
To see more of what she has to say about how Covid-19 has impacted Clinical Trials in Oncology, join us for our next panel discussion by signing up here.
